EUR 10.05
(0.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 6.6 Million EUR | 108.57% |
2022 | 3.16 Million EUR | -31.17% |
2021 | 4.59 Million EUR | 57.32% |
2020 | 2.92 Million EUR | -30.16% |
2019 | 4.18 Million EUR | 49.48% |
2018 | 2.79 Million EUR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 7.03 Million EUR | 6.66% |
2023 Q4 | 6.6 Million EUR | 44.51% |
2023 FY | 6.6 Million EUR | 108.57% |
2023 Q2 | 4.56 Million EUR | 44.33% |
2022 Q2 | 4.07 Million EUR | -11.26% |
2022 FY | 3.16 Million EUR | -31.17% |
2022 Q4 | 3.16 Million EUR | -22.44% |
2021 FY | 4.59 Million EUR | 57.32% |
2021 Q4 | 4.59 Million EUR | 36.15% |
2021 Q2 | 3.37 Million EUR | 15.55% |
2020 Q4 | 2.92 Million EUR | 0.0% |
2020 FY | 2.92 Million EUR | -30.16% |
2019 FY | 4.18 Million EUR | 49.48% |
2018 FY | 2.79 Million EUR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
MPH Health Care AG | - EUR | -Infinity% |
Dermapharm Holding SE | 320.75 Million EUR | 97.942% |
Evotec SE | 30.89 Million EUR | 78.634% |
MERCK Kommanditgesellschaft auf Aktien | 4.63 Billion EUR | 99.858% |
PharmaSGP Holding SE | 10.11 Million EUR | 34.763% |
SynBiotic SE | 2.76 Million EUR | -138.733% |